JP4520987B2 - チャイルドプルーフ微量栄養素サプリメント - Google Patents
チャイルドプルーフ微量栄養素サプリメント Download PDFInfo
- Publication number
- JP4520987B2 JP4520987B2 JP2006523501A JP2006523501A JP4520987B2 JP 4520987 B2 JP4520987 B2 JP 4520987B2 JP 2006523501 A JP2006523501 A JP 2006523501A JP 2006523501 A JP2006523501 A JP 2006523501A JP 4520987 B2 JP4520987 B2 JP 4520987B2
- Authority
- JP
- Japan
- Prior art keywords
- iron
- vitamin
- oral dosage
- micronutrient
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000011785 micronutrient Substances 0.000 title claims description 23
- 235000013369 micronutrients Nutrition 0.000 title claims description 23
- 239000013589 supplement Substances 0.000 title claims description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 88
- 229910052742 iron Inorganic materials 0.000 claims abstract description 41
- 239000000047 product Substances 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 239000011888 foil Substances 0.000 claims description 3
- 230000035935 pregnancy Effects 0.000 claims description 3
- 238000011282 treatment Methods 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 229930003270 Vitamin B Natural products 0.000 claims 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 2
- 235000020802 micronutrient deficiency Nutrition 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 235000019156 vitamin B Nutrition 0.000 claims 2
- 239000011720 vitamin B Substances 0.000 claims 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims 1
- 235000013734 beta-carotene Nutrition 0.000 claims 1
- 239000011648 beta-carotene Substances 0.000 claims 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims 1
- 229960002747 betacarotene Drugs 0.000 claims 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 229960000304 folic acid Drugs 0.000 claims 1
- 235000019152 folic acid Nutrition 0.000 claims 1
- 239000011724 folic acid Substances 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 229940055726 pantothenic acid Drugs 0.000 claims 1
- 235000019161 pantothenic acid Nutrition 0.000 claims 1
- 239000011713 pantothenic acid Substances 0.000 claims 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims 1
- 235000019154 vitamin C Nutrition 0.000 claims 1
- 239000011718 vitamin C Substances 0.000 claims 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims 1
- 235000020786 mineral supplement Nutrition 0.000 abstract description 7
- 229940029985 mineral supplement Drugs 0.000 abstract description 7
- 235000020772 multivitamin supplement Nutrition 0.000 abstract description 4
- 239000007787 solid Substances 0.000 abstract description 2
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 7
- 208000005374 Poisoning Diseases 0.000 description 6
- 231100000572 poisoning Toxicity 0.000 description 6
- 230000000607 poisoning effect Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 231100000518 lethal Toxicity 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 208000032484 Accidental exposure to product Diseases 0.000 description 2
- 206010022971 Iron Deficiencies Diseases 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 231100000636 lethal dose Toxicity 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- -1 130 mg Chemical compound 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 208000032754 Infant Death Diseases 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Mechanical Engineering (AREA)
- Food Science & Technology (AREA)
- Composite Materials (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Packages (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
出典: "The Merck Manual of Diagnosis and Therapy(メルクの診断と治療用マニュアル)"第16版、1992年、第2128頁、セクション"Pediatrics and Genetics(小児科学と遺伝学)"、"Injuries, Poisonings and Resuscitation(怪我、中毒と蘇生)"の章: タイトル"Iron Poisoning(鉄中毒)"
「鉄元素(Fe)の経口致死量は200〜250mg/kgであるが、
130mgといった少量の鉄元素が致命的なこともある。」
更に、Juurlink et al.の"Iron poisoning in young children: association with the birth of a sibling"、Canadian Medical Association Journal、2003年6月10日、168(12)、要約書を参照:
「鉄分は幼児の中毒死の主要な原因である。周産期の鉄分摂取療法が
一般的であるため、飴のような外観の治療用錠剤が家庭に存在することにより、
幼児がいる場合に誤飲事故の危険が考えられる。」
本発明の課題は、複数のチャイルドプルーフ特性を組み合わせた、新規な微量栄養素サプリメント投与用包装品を提供することである。
より詳細には、本発明の1つの態様によると、ブリスター容器に個別に入った複数の固形の経口服用単位の形態で提供される微量栄養素サプリメント包装品であって、一部の服用単位は鉄分を含有し、少なくとも半数の服用単位は実質的に鉄分を含有せず、好ましい態様においては、購入者に販売される該包装品の鉄元素の総量は約1300mg未満であり、最も好ましくは1050mg以下であることを特徴とする微量栄養素サプリメント包装品が提供される。
最も好ましい態様においては、本発明は、時間間隔を置いて摂取する2種の個別の服用単位の形態の微量栄養素サプリメントを開示する。即ち、異なる服用単位を所定の時間間隔で摂取する1日2回服用処方(twice-a-day formulation)で服用単位を提供する。
図1に参照する。本発明の好ましい形態は、このように種類によって仕分けした2種の個別の服用単位を含む投与キットである。図1は、ある所定時刻に摂取すべき服用単位の入ったブリスター容器[12]の一揃えと、別の所定時刻に摂取すべき服用単位の入ったブリスター容器[14]の一揃えを有する、1週間分の本発明のサプリメントのブリスター包装品[10]である。ブリスター包装品5個を1箱にまとめ(図示しない)、1ヶ月分のパックとして販売することが好ましい。またこのような服用単位のパックは、30日分の服用単位として、7日分のブリスター包装品を1セットとするものを4セットと2日分のブリスター包装品を1セットとするものを1セットを含むことが更に好ましい。
Claims (10)
- チャイルドプルーフ微量栄養素サプリメントのキットであって、
包装品において、2種の経口服用単位を包含し、少なくとも半数の経口服用単位は実質的に鉄分を含有せず、残りの経口服用単位は鉄分を含有し、
市販される包装品の鉄元素の総量は約1300mg未満であり、
鉄分を含有する経口服用単位を実質的に鉄分を含有しない経口服用単位から識別するための情報を含む投与指示書をさらに包含し、
鉄分を含有する第1経口服用単位と、実質的に鉄分を含有しない第2経口服用単位からなる2種の経口服用単位による1日2回服用処方として提供される、
ことを特徴とするキット。 - 鉄元素の総量が1050mg以下であることを特徴とする、請求項1に記載のキット。
- 市販される包装品が、約1ヶ月分の微量栄養素サプリメントを含み、鉄分を含有する経口服用単位のそれぞれの鉄元素の総量が約35mgであることを特徴とする、請求項1に記載のキット。
- 経口服用単位が錠剤であることを特徴とする、請求項1〜3のいずれかに記載のキット。
- 第1経口服用単位と第2経口服用単位とがカラーコードにより識別可能であることを特徴とする、請求項1〜4のいずれかに記載のキット。
- 7日分の経口服用単位のブリスター包装品を一揃えとするものを4セットと、2日分の経口服用単位のブリスター包装品を一揃えとするものを1セット包含し、該ブリスター包装品は、経口服用単位を含むプラスチック製のブリスター容器を、幼児が破り開けるのが困難な規格のアルミホイルで密閉したものであることを特徴とする、請求項3に記載のキット。
- 微量栄養素欠乏症の治療または予防における、請求項1〜6のいずれかのチャイルドプルーフ微量栄養素サプリメントのキットの使用。
- 妊娠可能年齢の女性における微量栄養素欠乏症の治療または予防における、請求項1〜6のいずれかのチャイルドプルーフ微量栄養素サプリメントのキットの使用。
- 該女性が妊娠中、出産後または妊娠を計画していることを特徴とする、請求項8に記載の使用。
- 微量栄養素サプリメントが、β−カロチン、ビタミンE、ビタミンC、ビタミンB1、ビタミンB2、ビタミンB3、ビタミンB6、パントテン酸、ビタミンD3、ビタミンB12、葉酸、カルシウム、マグネシウム、ヨウ素、銅及び亜鉛よりなる群から選ばれる少なくとも1種を更に含有することを特徴とする請求項1〜6のいずれかに記載のキット。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2438160 | 2003-08-21 | ||
PCT/CA2004/001547 WO2005019061A1 (en) | 2003-08-21 | 2004-08-20 | Micronutrient supplement dispensing package |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007502750A JP2007502750A (ja) | 2007-02-15 |
JP2007502750A5 JP2007502750A5 (ja) | 2007-10-04 |
JP4520987B2 true JP4520987B2 (ja) | 2010-08-11 |
Family
ID=34200805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006523501A Expired - Fee Related JP4520987B2 (ja) | 2003-08-21 | 2004-08-20 | チャイルドプルーフ微量栄養素サプリメント |
Country Status (6)
Country | Link |
---|---|
US (3) | US20050112194A1 (ja) |
EP (1) | EP1656307A4 (ja) |
JP (1) | JP4520987B2 (ja) |
CN (1) | CN1835870B (ja) |
AU (1) | AU2004266741B2 (ja) |
WO (1) | WO2005019061A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050112211A1 (en) * | 2003-08-21 | 2005-05-26 | Eric Gervais | Micronutrient supplement |
US8943780B1 (en) | 2007-05-30 | 2015-02-03 | Walgreen Co. | Method and system for verification of product transfer from an intermediate loading cartridge to a multi-container blister pack |
US7866476B2 (en) | 2007-05-30 | 2011-01-11 | Walgreen Co. | Multi-dose blister card pillbook |
US8251219B1 (en) | 2007-10-22 | 2012-08-28 | Walgreen Co. | Package for medicine |
US7937911B1 (en) | 2008-11-21 | 2011-05-10 | Walgreen Co. | Method of preparing a blister card |
US8777013B1 (en) | 2013-03-15 | 2014-07-15 | The Challenge Printing Company | Packaging for pharmaceuticals including contraceptives |
EP2923966A1 (en) * | 2014-03-28 | 2015-09-30 | The Challenge Printing Company | Packaging for pharmaceuticals including contraceptives |
KR101815371B1 (ko) | 2016-02-26 | 2018-01-04 | 인제대학교 산학협력단 | 연고사용방법 |
US20230114628A1 (en) * | 2020-07-31 | 2023-04-13 | Ellement Inc. | Prenatal Dosage Forms, Methods of Administration and Kits Thereof |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL58649A (en) * | 1978-11-10 | 1982-04-30 | Beecham Group Ltd | Pharmaceutical dispensing container |
US4431634A (en) * | 1981-12-21 | 1984-02-14 | American Cyanamid Company | Prenatal iron supplements |
US4706815A (en) * | 1982-08-23 | 1987-11-17 | American Home Products Corporation | Dispensing container for triphasic |
US4752479A (en) * | 1986-05-27 | 1988-06-21 | Ciba-Geigy Corporaton | Multi vitamin and mineral dietary supplement with controlled release bioavailable iron |
CA1319612C (en) * | 1987-07-02 | 1993-06-29 | Haile Mehansho | Iron-calcium mineral supplements with enhanced bioavailability |
GB2212396A (en) * | 1987-12-18 | 1989-07-26 | Procter & Gamble | Dietary supplement comprising calcium and delayed release coated iron |
CA2064959C (en) * | 1992-04-02 | 2000-09-19 | Laura Rea | Unit dose packaging |
ATE234610T1 (de) * | 1992-09-23 | 2003-04-15 | Kv Pharmaceutical Corp | Multivitamin- und mineralstoffergänzung für schwangere |
AU5363094A (en) * | 1992-10-21 | 1994-05-09 | Procter & Gamble Company, The | Concentrated bioavailable calcium source |
US5869084A (en) * | 1994-06-20 | 1999-02-09 | K-V Pharmaceuticals Co. | Multi-vitamin and mineral supplements for women |
US5932624A (en) * | 1995-10-17 | 1999-08-03 | Herbert; Victor D. | Vitamin supplement composition |
US6133318A (en) * | 1995-11-15 | 2000-10-17 | Hart; Francis J. | Oxalic acid or oxalate compositions and methods for bacterial, viral, and other diseases or conditions |
US5948443A (en) * | 1996-02-23 | 1999-09-07 | Medical Doctor's Research Institute, Inc. | Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease |
US5788974A (en) * | 1996-09-11 | 1998-08-04 | D'amico; Steven A. | Helicobacter pylori treatment compliance pack |
US5976568A (en) * | 1997-02-21 | 1999-11-02 | Medical Doctors' Research Institute, Inc. | Modular system of dietary supplement compositions for optimizing health benefits and methods |
US6077530A (en) * | 1997-07-28 | 2000-06-20 | Weinstein; Robert | Analgesic dosage units for coordinated administration |
US5945123A (en) * | 1998-04-02 | 1999-08-31 | K-V Pharmaceutical Company | Maximizing effectiveness of substances used to improve health and well being |
JP2000316525A (ja) * | 1999-05-10 | 2000-11-21 | Bizan Yakuhin Kk | 卵黄油の健康食品 |
US6375956B1 (en) * | 1999-07-22 | 2002-04-23 | Drugtech Corporation | Strip pack |
US6521247B1 (en) * | 1999-08-13 | 2003-02-18 | Warner Chilcott Laboratories Ireland Limited | Dual iron containing nutritional supplement |
US6161699A (en) * | 1999-10-29 | 2000-12-19 | Proclinical, Inc. | Child-resistant blister package |
US6569445B2 (en) * | 2000-12-05 | 2003-05-27 | Pbm Pharmaceuticals, Inc. | Food bars containing nutritional supplements and anti-constipation and regularity maintaining-agents |
US6576253B2 (en) * | 2000-12-05 | 2003-06-10 | Pbm Pharmaceuticals, Inc. | Food bars containing nutritional supplements |
US20020094970A1 (en) * | 2000-12-14 | 2002-07-18 | Ronenn Roubenoff | Compositions and methods for treating an arthritic condition |
RU2195269C2 (ru) * | 2001-02-14 | 2002-12-27 | Общество с ограниченной ответственностью "МДТ" | Витаминно-минеральный комплекс |
US6412636B1 (en) * | 2001-05-21 | 2002-07-02 | Westvaco Corporation | Unit dose packaging system with child resistance and senior friendly features |
ES2557741T3 (es) * | 2002-03-27 | 2016-01-28 | Immunex Corporation | Procedimientos para incrementar la producción de polipéptidos |
US7994217B2 (en) * | 2002-05-02 | 2011-08-09 | Xanodyne Pharmaceuticals, Inc. | Prenatal multivitamin/multimineral supplement |
-
2004
- 2004-08-20 US US10/922,800 patent/US20050112194A1/en not_active Abandoned
- 2004-08-20 JP JP2006523501A patent/JP4520987B2/ja not_active Expired - Fee Related
- 2004-08-20 EP EP04761711A patent/EP1656307A4/en not_active Withdrawn
- 2004-08-20 WO PCT/CA2004/001547 patent/WO2005019061A1/en active Search and Examination
- 2004-08-20 AU AU2004266741A patent/AU2004266741B2/en not_active Ceased
- 2004-08-20 CN CN2004800236095A patent/CN1835870B/zh not_active Expired - Fee Related
-
2011
- 2011-08-22 US US13/214,961 patent/US20110305775A1/en not_active Abandoned
-
2013
- 2013-09-11 US US14/024,005 patent/US20140010765A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2004266741A1 (en) | 2005-03-03 |
CN1835870A (zh) | 2006-09-20 |
EP1656307A1 (en) | 2006-05-17 |
AU2004266741B2 (en) | 2008-01-03 |
US20140010765A1 (en) | 2014-01-09 |
WO2005019061A1 (en) | 2005-03-03 |
JP2007502750A (ja) | 2007-02-15 |
CN1835870B (zh) | 2010-07-21 |
US20050112194A1 (en) | 2005-05-26 |
US20110305775A1 (en) | 2011-12-15 |
EP1656307A4 (en) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20140010765A1 (en) | Micronutrient supplement dispensing package | |
US6323188B1 (en) | Treatment and prevention of cardiovascular diseases, heart attack, and stroke, primary and subsequent, with help of aspirin and certain vitamins | |
US6121249A (en) | Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins | |
Fontaine | Conclusions and recommendations of the WHO Consultation on prevention and control of iron deficiency in infants and young children in malaria-endemic areas. | |
Viteri | Iron supplementation for the control of iron deficiency in populations at risk | |
Gautam et al. | Iron deficiency in pregnancy and the rationality of iron supplements prescribed during pregnancy | |
US20060127499A1 (en) | Vitamin-mineral compositions | |
Talaulikar et al. | Vitamin C as an antioxidant supplement in women's health: a myth in need of urgent burial | |
JP2007533607A (ja) | 微量栄養素サプリメント | |
JP2007502750A5 (ja) | ||
US20020022058A1 (en) | Unit dose of material in system and method | |
US7556150B2 (en) | Dispenser for progestin used for acute and maintenance treatment of DUB | |
Sajith et al. | Correlations of adherence to iron supplements and prevalence of anemia in antenatal women | |
MXPA05010930A (es) | Suplemento multivitaminico y mineral para mujeres embarazadas. | |
DE29916231U1 (de) | Multivitamin- und -mineralpräparat | |
US8454951B2 (en) | Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women | |
CA2478163C (en) | Childproof micronutrient supplement | |
Resu et al. | Neutraceuticals and nutrivigilance-present scenario in India | |
US9125844B1 (en) | Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women | |
RU2250043C9 (ru) | Витаминно-минеральный комплекс, способ его изготовления и способ его приема | |
Sekkoum | Development of the composition of a vitamine medicine in the form of an effervescent powder | |
Dugoua | Vitamins, minerals, trace elements, and dietary supplements | |
Cohen | FDA's iron will | |
Goldberg et al. | The Best Supplements for Your Health | |
Hingley | Preventing childhood poisoning |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070814 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070814 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20091120 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100204 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100517 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100521 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130528 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4520987 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140528 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |